Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adant in Symptomatic Hip Osteoarthritis
NCT00330135Phase 3Terminated
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2005
- Primary completion
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sodium hyaluronate in osteoarthritis (OA), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2005; status: terminated.
02
Drugs
sodium hyaluronate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00330135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330135.